Hematological and biochemical profiles in children with cerebral palsy: A cross-sectional study

Rohit Khandelwal1, Vivek Vankalapati Manjunath1, Leeni Mehta2

  • 1Department of Paediatrics, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India.

Insights

Anemia and abnormal alkaline phosphatase levels are more common in children with cerebral palsy, particularly in younger males and females, respectively. These findings aid in improving patient care through timely interventions.

Area of Science:

  • Pediatric Neurology
  • Clinical Biochemistry
  • Hematology

Background:

  • Cerebral palsy (CP) is a prevalent pediatric neurological disorder often accompanied by nutritional challenges.
  • Hematological and biochemical markers are crucial for assessing the health status of children with CP.
  • Limited research has comprehensively analyzed these parameters in pediatric CP populations.

Purpose of the Study:

  • To characterize the hematological and biochemical profiles of children diagnosed with cerebral palsy.
  • To investigate the influence of age and gender on these parameters in pediatric CP.

Main Methods:

  • A four-year observational study involving children with CP admitted to a pediatric department.
  • Collected data on hemoglobin, platelet count, white blood cell (WBC) count, red blood cell (RBC) indices, and various biochemical markers.
  • Performed age and gender-specific analyses to identify trends and significant differences.

Main Results:

  • Average hemoglobin: 11.48 mg/dL; average platelet count: 301.24×10^9/L; average WBC count: 11.13×10^9/L.
  • Anemia was more prevalent in males under nine years old. Low platelet counts (<150×10^9/L) were found in 4.96% of patients.
  • Abnormal alkaline phosphatase levels were significantly more common in younger children (<9 years) and females compared to males.

Conclusions:

  • Anemia disproportionately affects younger males with cerebral palsy.
  • Bone turnover markers, such as alkaline phosphatase, show higher abnormality rates in young patients and females with CP.
  • Understanding age and gender-specific parameter variations can guide timely interventions, enhancing the quality of life for children with CP.
Abstract

Related Concept Videos